Skip to main content
Signal8

Greene Barry E

SEC insider (Form 3/4/5 filer). CIK 0001291963. Director at CITY THERAPEUTICS, INC. (CTY) and 3 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Oct 15, 2026. Located in CAMBRIDGE, MA.

Companies Greene Barry E has filed insider reports for

  • CITY THERAPEUTICS, INC. (CTY): Director
  • Dyne Therapeutics, Inc. (DYN): Director
  • Karyopharm Therapeutics Inc. (KPTI): Director
  • Sage Therapeutics, Inc. (SAGE): Director, Officer, President and CEO
Greene Barry E profile photo

Greene Barry E

CIK: 0001291963

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)3 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

CITY THERAPEUTICS, INC. logo
CTY

CITY THERAPEUTICS, INC.

Director
Dyne Therapeutics, Inc. logo
DYN

Dyne Therapeutics, Inc.

Director
Karyopharm Therapeutics Inc. logo
KPTI

Karyopharm Therapeutics Inc.

Director
Sage Therapeutics, Inc. logo
SAGE

Sage Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

  • CITY THERAPEUTICS, INC. logo
    CTY

    CITY THERAPEUTICS, INC.

    Oct 15, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    22.6K shares-
  • Dyne Therapeutics, Inc. logo
    DYN

    Dyne Therapeutics, Inc.

    Jun 22, 2026
    Award

    Stock option (right to buy)

    Direct
    57.5K shares-
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    May 21, 2026
    Award
    Direct
    15.5K shares-
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Jul 31, 2025
    Tender Offer
    Direct
    46.9K shares-
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Jul 31, 2025
    Disposition
    Direct
    53.2K shares-
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    May 28, 2025
    Award

    Nonstatutory Stock Option (right to buy)

    Direct
    4.6K shares-
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Apr 10, 2025
    Tax Payment
    Direct
    4.9K shares at avg. $6.91$34K
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Apr 10, 2025
    Award
    Direct
    20K shares-
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Jan 16, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    174K shares-

1-9 of 9